Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells

Journal of Vascular Research

Volumn 42, Issue 4, 2005, Pages 275-283

  Weis, Margaret T ^a   Brady, Monica ^a   Moore, Mike ^a   Crumley, Jason ^a   Stallone, John N ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Endothelial factors; Endothelial function; Fatty acyl CoA synthetase; Nitric oxide

Indexed keywords

ANGIOTENSIN; ARACHIDONIC ACID; ARACHIDONOYL COENZYME A; BRADYKININ; FATTY ACID; FENOFIBRATE; INDUCIBLE NITRIC OXIDE SYNTHASE; IONOMYCIN; ISOPRENALINE; LONG CHAIN FATTY ACID COENZYME A LIGASE; NITRIC OXIDE SYNTHASE; PALMITOYL COENZYME A; PHENYLEPHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTACYCLIN; TRIACSIN C; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; METABOLITE; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RAT; SYNTHESIS;

AORTA; ARACHIDONIC ACID; CELLS, CULTURED; COENZYME A LIGASES; CORONARY VESSELS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; EPOPROSTENOL; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRIAZENES;

EID: 23844521730     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085847     Document Type: Article

References (35)

1. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D: Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-315.
2. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999;100:354-360.
3. Liu J, Hughes TE, Sessa WC: The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: A green fluorescent protein study. J Cell Biol 1997;277:33032-33040.
4. García-Cardeñas G, Martasek P, Masters BSS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC: Dissecting the interaction between nitric oxide synthase and caveolin. J Biol Chem 1997;272:25437-25440.
5. Ju H, Zou R, Venema VJ, Venema RC: Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 1997;272:18522-18525.
6. Michel JB, Feron O, Sase K, Prabhakar P, Michel T: Caveolin versus calmodulin-counter-balancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 1997;272:25907-25912.
7. Michel T, Li GK, Busconi L: Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1993;90:6252-6256.
8. Robinson LJ, Busconi L, Michel T: Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem 1995;270:995-998.
9. Robinson LJ, Michel T: Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci USA 1995;92:11776-11780.
10. Campbell WB, Gebremedhin D, Pratt PF, Harder DR: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78:415-423.
11. Weintraub NL, Fang X, Kaduce TL, VanRollins M, Chatterjee P, Spector AA: Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ Res 1997;81:258-267.
12. Knoll LT, Schall OF, Suzuki I, Gokel GW, Gordon JI: Comparison of the reactivity of tetradecenoic acids, a triacsin and unsaturated oximes with four purified Saccharomyces cerevisiae fatty acid activation proteins. J Biol Chem 1995;270:20090-20097.
13. Korchak HM, Kane LH, Rossi MW, Corkey BE: Long chain acyl coenzyme A signaling in neutrophils: An inhibitor of acyl coenzyme A synthetase, triacsin-C, inhibits superoxide anion generation and degranulation by human neutrophils. J Biol Chem 1994;269:30281-30287.
14. Noel RJ, Antinozzi PA, McGarry DJ, Newgard CB: Engineering of glycerol-stimulated insulin secretion in islet beta cells: Differential metabolic fates of glucose and glycerol provide insight into mechanisms of stimulus-secretion coupling. J Biol Chem 1997;272:18621-18627.
15. Tomoda H, Igarishi K, Cyong J-C, Omura S: Evidence for an essential role of long chain acyl CoA synthetase in animal cell proliferation: Inhibition of long chain acyl CoA synthetase by triacsins caused inhibitions of Raji cell proliferation. J Biol Chem 1991;266:4214-4219.
16. Omura S, Tomoda H, Xu QM, Takahashi Y, Iwai Y: Triacsins, new inhibitors of acyl-CoA synthetase produced by Streptomyces sp. J Antibiotics 1986;39:1211-1218.
17. Vessey DA, Kelley M, Warren RS: Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acyl:Co A ligases of human liver. J Biochem Mol Toxicol 2004;18:100-106.
18. Weis MT, Crumley J, Young LH, Stallone JN: Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium. Cardiovasc Res 2004;63:338-346.
19. Yoshida K, Okamoto M, Unehara K, Iwami M, Kohsaka M, Aoki H, Imanaka H: Studies on new vasodilators, WS-1228A and B. 1. Discovery, taxonomy, isolation and characterization. J Antibiotics 1982;35:151-156.
20. Kaduce TL, Fang X, Harmon SD, Oltman CL, Dellsperger KC, Teesch LM, Gopal VR, Falck JR, Campbell WB, Weintraub NL, Spector AA: 20-Hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. J Biol Chem 2004;279:2648-2656.
21. Schoonjans K, Staels B, Grimaldi P, Auwerx J: Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. Eur J Biochem 1993;216:615-622.
22. Campbell WB, Falck JR, Gauthier K: Role of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors in bovine coronary arteries. Med Sci Monitor 2001;7:578-584.
23. Gauthier KM, Jagadeesh SG, Falck JR, Campbell WB: 14,15-epoxyeicosa-5(Z)- enoic-mSI: A 14,15-and 5,6-EET antagonist in bovine coronary arteries. Hypertension 2003;42:555-561.
24. 2 activity and leukotriene C4 release. J Pharmacol Exp Ther 1998;284:847-857.
25. Stallone JN: Sex differences in mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in rats. Am J Physiol 1995;268:R40-R49.
26. Feron O, Saldana F, Miche JB, Michel T: The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem 1998;273:3125-3128.
27. Kim JH, Lewin TM, Coleman RA: Expression and characterization of recombinant rat acyl-CoA synthetases 1, 4, and 5: Selective inhibition by triacsin C and thiazolidines. J Biol Chem 2001;276:24667-24673.
28. Lewin TM, Kim JH, Granger DA, Vance JE: Acyl CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem 2001;276:26474-24679.
29. Hartman EJ, Omura S, Laposata M, Triacsin C: A differential inhibitor of arachidonoyl CoA synthetase and nonspecific long-chain acyl CoA synthetase. Prostaglandins 1989;37:655-671.
30. Igal RA, Wang P, Coleman RA: Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: Evidence for functionally separate pools of acyl-CoA. Biochem J 1997;324:529-534.
31. Li J, Wurtman RJ: Heterogeneous long chain acyl-CoA synthetases control distribution of individual fatty acids in newly-formed glycerolipids of neuronal cells undergoing neurite outgrowth. Neurochem Res 1999;24:739-750.
32. Beltramo M, Piomelli D: Carrier-mediated transport and enzymatic hydrolysis of endogenous canabinoid 2-arachidonylglycerol. Neuroreport 2000;11:1231-1235.
33. Oh-ishi S, Yamaki K, Abe M, Tomoda H, Omura S: The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes. Jap J Pharmacol 1992;59:417-418.
34. Schwartzman M, Liberman E, Raz A: Bradykinin and angiotensin II activation of arachidonic acid deacylation and prostaglandin ET formation in rabbit kidney: Hormone sensitive versus hormone insensitive lipid pools of arachidonic acid. J Biol Chem 1981;256:2329-2333.
35. ++. Biochem J 1996;313:849-853.